Description

NEURONOX 100U is a botulinum toxin type A internationally recognized as a safe and effective alternative to Ona-BoNT/A (Botox®) for the reduction of moderate to severe glabellar lines.

Developed by the Korean pharmaceutical company Medy-Tox Inc., NEURONOX is registered in more than 30 countries, including Korea, Brazil, India, Mexico, Thailand and Ukraine, and continues to expand its global presence.

Its advanced formulation allows high toxin production and potency in less time, ensuring clinical efficacy, consistent results and precise action on the muscles responsible for dynamic wrinkles.

Benefits

  • Proven alternative to Botox® (Ona-BoNT/A).
  • High toxin potency and stability.
  • Natural, long-lasting results.
  • Clinically validated safety profile.
  • Widely approved and used internationally.
  • High efficacy in localized muscle relaxation.

Treatment areas

  • Lip contour (relaxation of the orbicularis muscle).
  • Deep wrinkles on the forehead and glabella.
  • Nasolabial folds.
  • Crow's feet and periocular wrinkles.
  • Blepharospasm (eyelid spasm).
  • Hyperhidrosis (excessive sweating).
  • Facial lifting with toxin.

Main ingredients

Clostridium Botulinum Toxin Type A (strain: Clostridium Botulinum CBFC26)

Packaging

1 vial (100 units per box)


Frequently asked questions

What makes Neuronox different from other botulinum toxins?
It has high potency and a high purity rate, comparable to Botox®, with efficacy proven in international clinical studies.

How long do the effects last?
Results usually last 4 to 6 months, depending on the treated area and the patient's individual response.

In which countries is it approved?
Neuronox is registered in more than 30 countries, including South Korea, Brazil, India, Mexico and Thailand.

When do results start to show?
Usually 3 to 5 days after application, reaching maximum effectiveness in two weeks.

Is it a safe product?
Yes. Neuronox meets strict international manufacturing and quality control standards, backed by the pharmaceutical company Medy-Tox Inc.